{"id": "chatcmpl-8Ja8RCGyYrj1d7cIFmch9KG65lmBP", "object": "chat.completion", "created": 1699677827, "model": "gpt-4-0613", "choices": [{"index": 0, "message": {"role": "assistant", "content": "1. Riociguat was used on inoperable patients.\n2. The number of inoperable patients treated with Riociguat was 189.\n3. Riociguat decreased pulmonary vascular resistance (PVR) in inoperable patients.\n4. The least-squares mean difference of PVR in inoperable patients treated with Riociguat was -285 dyn s/cm5.\n5. The 95% confidence interval for the decrease in PVR in inoperable patients treated with Riociguat was -357 to -213.\n6. The p-value for the decrease in PVR in inoperable patients treated with Riociguat was less than 0.0001.\n7. Riociguat was used on persistent/recurrent patients.\n8. The number of persistent/recurrent patients treated with Riociguat was 72.\n9. Riociguat decreased pulmonary vascular resistance (PVR) in persistent/recurrent patients.\n10. The least-squares mean difference of PVR in persistent/recurrent patients treated with Riociguat was -131 dyn s/cm5.\n11. The 95% confidence interval for the decrease in PVR in persistent/recurrent patients treated with Riociguat was -214 to -48.\n12. The p-value for the decrease in PVR in persistent/recurrent patients treated with Riociguat was 0.0025."}, "finish_reason": "stop"}], "usage": {"prompt_tokens": 112, "completion_tokens": 290, "total_tokens": 402}, "temperature": 0, "max_tokens": 512, "top_p": 1, "frequency_penalty": 0, "presence_penalty": 0, "messages": [{"role": "system", "content": "Statement: Riociguat decreased pulmonary vascular resistance (PVR) in inoperable (n=189; least-squares mean difference: \u2212285 dyn s/cm5 (95% CI \u2212357 to \u2212213); p<0.0001) and persistent/recurrent (n=72; \u2212131 dyn s/cm5 (95% CI \u2212214 to \u221248); p=0.0025) patients.\n\nList all the facts we explicitly know from the statement. Make each fact as atomic as possible."}]}